MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial 

Mitchell J.M., Ot’alora M.G., van der Kolk B., Shannon, S., Bogenschutz M., Gelfand, Y., Paleos, C., Nicholas, C.R., Quevedo, S., Balliett, B., Hamilton, S., Mithoefer M., Kleiman, S., Parker-Guilbert, K., Tzarfaty, K., Harrison, C., deBoer, A., Doblin, R., Yazar-Klosinski, B., MAPP2 Study Collaborator Group

Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder

Singleton, S. P, Wang, J., Mithoefer, M., Hanlon, C., George, M., Mithoefer, A., Mithoefer, O., Coker, A., Yazar-Klosinski, B., Emerson, A., Dolin, R., Kuceyeski, A. (2023)

MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder

Christie, D., Yazar-Klosinski, B., Nosova, E., Kryskow, P., Siu, W., Lessor, D., Argento, E. (2022)

MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial

Ching, T., Williams, M., Wang, B., Jerome, L., Yazar-Klosinski, B., Emerson, A., Doblin, R.. (2022)

MDMA-Assisted Therapy Significantly Reduces Eating Disorder Symptoms in a Randomized Placebo-Controlled Trial of Adults With Severe PTSD

Brewerton, T., Wang, J., Lafrance, A., Pamplin, C., Mithoefer, M., Yazar-Klosinki, B., Emerson, A., Doblin, R. (2022)

The Effects of MDMA-Assisted Therapy on Alcohol and Substance Use in a Phase 3 Trial for Treatment of Severe PTSD

Nicholas, C., Wang, J., Coker, A., Mitchell, J., Klairee, S., Yazar-Klosinski, B., Emerson, A., Brown.,  Doblin, R. (2022)

A Randomized Controlled Trial of 3,4-Methylenedioxymethamphetamine (MDMA) and Fear Extinction Retention in Healthy Adults

Maples-Keller, J. L., Norrholm, S., Burton, M., Reiff, C., Coghlan, C., Jovanovic, T., Yasinski, C., Jarboe, K., Rakofsky, J., Rauch, S., Dunlop, B.W., Rothbaum, B.O. (2022)

MDMA-Assisted Therapy for Posttraumatic Stress Disorder: A Mixed-Methods Case Study of a Participant of Color From an Open-Label Trial

Ching, T., Williams, M., Reed, S., Kisicki, M., Wang, J., Yazar-Klosinski, B., Emerson, A., Doblin, R.. (2022)

Three regulatory compliant test systems show no signs of MDMA-related genotoxicity

Ponte, L., Jerome, L., Hamilton, S., Mithoefer, M.C., Yazar-Klosinski, B.B., Vermetten, E. and Feduccia, A.A. (2021)

Reply to: Caution at psychiatry’s psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy

Mitchell J, Coker A, Yazar-Klosinski B. (2021)

Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder

Ponte, L., Jerome, L., Hamilton, S., Mithoefer, M.C., Yazar-Klosinski, B.B., Vermetten, E. and Feduccia, A.A. (2021)

Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder

Wang, J. B., Lin, J., Bedrosian, L., Coker, A., Jerome, I., Feduccia, A., Lilienstein, A., Harrison, C., Heimler, E., Mithoefer, M., Mithoefer, A., Ot’alora G., M., Poulter, B., Carlin, S., Matthews, R., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (2021)

MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study

Mitchell, J.M., Bogenschutz, M., Lilienstein, A. et al. (2021)

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials

Jerome, L., Feduccia, A. A., Wang, J. B., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2020)

Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy

Feduccia, A. A., Jerome, L., Mithoefer, M. C., & Holland, J. (2020)

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study.

Wolfson, P. E., Andries, J., Feduccia, A. A., Jerome, L., Wang, J. B., Williams, E., … & Emerson, A. (2020)

Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.

Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020)

MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial

Candice M. Monson, Anne C. Wagner, Ann T. Mithoefer, Rachel E. Liebman, Allison A. Feduccia, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin & Michael C. Mithoefer (2020)

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.

Feduccia, A.A., Jerome, L., Yazar-Klosinski, B., Emerson, A., Mithoefer, A., Doblin, R. (2019)

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R. (2019)

3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats

Hake HS, Davis JKP, Wood RR, Tanner MK, Loetz EC, Sanchez A, Ostrovskyy M, Oleson EB, Grigsby J, Doblin R, Greenwood BN. (2019)

The past and future of psychedelic science: an introduction to this issue.

Doblin, R. E., Christiansen, M., Jerome, L., & Burge, B. (2019)

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

Mithoefer, M.C., Feduccia, A.A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Doblin, R. (2019)

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.

Ot’alora, G, M., Grigsby, J., Poulter, B., Van Derveer, J. W., Giron, S. G., Jerome, L., Feduccia, A., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Mithoefer, M., Doblin, R. (2018)

Reduction in Social Anxiety After MDMA-Assisted Psychotherapy with Autistic Adults: A Randomized, Double-blind, Placebo-Controlled Pilot Study.

Danforth, A.L., Grob, C.S., Struble, C., Feduccia, A.A., Walker, N., Jerome, L., Yazar-Klosinski, B., Emerson, A. (2018)

3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy for Post-Traumatic Stress Disorder in Military Veterans, Firefighters, and Police Officers: A Randomised, Double-Blind, Dose-Response, Phase 2 Clinical Trial.

Mithoefer, M. C., Mithoefer, Mithoefer, A. T., Feduccia, A. A., Jerome, L., Wagner, M., Wymer, J., Holland, J., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Doblin, R. (2018)

Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study

Noller, G, Frampton, C, Yazar-Klosinski, B (2017)

Potential Psychiatric Uses for MDMA.

Yazar‐Klosinski, B., Mithoefer, M. (2017)

MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults.

Danforth A, Struble C, Yazar-Klosinski B, Grob C (2016)

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen R (2014)

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study​.

Mithoefer M, Wagner M, Mithoefer A, Jerome L, Martin S, Yazar-Klosinski B, Michel Y, Brewerton T, Doblin R (2013)

Can MDMA Play a Role in the Treatment of Substance Abuse?

Jerome L, Schuster S, Yazar-Klosinski B (2013)

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.

Mithoefer M, Wagner M, Mithoefer A, Jerome L, Doblin R (2010)

The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.

Sumnall H, Cole J, Jerome L (2006)

The effects of stereotype threat on cognitive function in ecstasy users.

Cole, J. C., Michailidou, K., Jerome, L., & Sumnall, H. R. (2006)